Shankar Hariharan - 25 Jul 2024 Form 3 Insider Report for TRxADE HEALTH, INC (SCNX)

Role: Director
Signature: /s/ Louis Kern as attorney-in-fact for Shankar Hariharan
Issuer symbol: SCNX
Transactions as of: 25 Jul 2024
Net transactions value: $0
Form type: 3
Filing time: 05 Aug 2024, 21:23:01 UTC
Next filing: 12 Mar 2026
SEC: View on sec.gov

Quoteable Key Fact

"Shankar Hariharan filed Form 3 for TRxADE HEALTH, INC (SCNX) on 05 Aug 2024."

Quick Takeaways

This page summarizes Shankar Hariharan's Form 3 filing for TRxADE HEALTH, INC (SCNX).
0 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 05 Aug 2024, 21:23.

What Changed

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MEDS	Common Stock, par value $0.00001						81,863	25 Jul 2024	Direct	F1
holding	MEDS	Common Stock, par value $0.00001						15,224	25 Jul 2024	By spouse	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MEDS	Series X Non-Voting Convertible Preferred Stock							25 Jul 2024	Common Stock	1,916,816	$0.000000	Direct	F1, F2
holding	MEDS	Series X Non-Voting Convertible Preferred Stock							25 Jul 2024	Common Stock	356,480	$0.000000	By spouse	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities of TRxADE HEALTH, INC. (the "Issuer") were issued in connection with the closing of the acquisition of Scienture, Inc. ("Scienture") by the Issuer on July 25, 2024 (the "Merger") pursuant to an Agreement and Plan of Merger entered into by the Issuer, certain subsidiaries of the Issuer, and Scienture (the "Merger Agreement").
F2	These shares of the Issuer's Series X Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the "Preferred Stock"), have no expiration date. On the 20th calendar day following the mailing of an information statement on Schedule 14C that the Issuer is filing with the Securities and Exchange Commission and mailing to its stockholders in connection with the closing of the Merger, these shares of Preferred Stock will automatically convert on a 1-for-1 basis into fully paid and nonassessable shares of the Issuer's common stock, par value $0.00001.

Content

These securities of TRxADE HEALTH, INC. (the "Issuer") were issued in connection with the closing of the acquisition of Scienture, Inc. ("Scienture") by the Issuer on July 25, 2024 (the "Merger") pursuant to an Agreement and Plan of Merger entered into by the Issuer, certain subsidiaries of the Issuer, and Scienture (the "Merger Agreement").

These shares of the Issuer's Series X Non-Voting Convertible Preferred Stock, par value $0.00001 per share (the "Preferred Stock"), have no expiration date. On the 20th calendar day following the mailing of an information statement on Schedule 14C that the Issuer is filing with the Securities and Exchange Commission and mailing to its stockholders in connection with the closing of the Merger, these shares of Preferred Stock will automatically convert on a 1-for-1 basis into fully paid and nonassessable shares of the Issuer's common stock, par value $0.00001.

Remarks:

Exhibit List - Exhibit 24.1: Power of Attorney (Shankar Hariharan)